https://orcid.org/0000-0003-2470-0530
Figures & data
Figure 1 Flowchart illustrating inclusion of both general practitioners (GPs) and patients with chronic obstructive pulmonary disease (COPD) in the study. Feedback from the digital clinical decision–support system (CDSS) prevented inclusion of screen failures among GPs using the CDSS if spirometry did not show airway obstruction.
Table 1 Characteristics of patients and GPs in the intervention and the control groups
Table 2 Comparison of characteristics between COPD and misdiagnosed patients
Figure 2 (A) Correlation between COPD-assessment test (CAT) and modified Medical Research Council (mMRC) dyspnea-scale scores (n=149, r=0.47; P<0.001. (B) Distribution of CAT scores (median) according to mMRC score. Error bars represent the interquartile range.
Figure 3 GOLD ABCD treatment groups in COPD patients defined by COPD-assessment test (CAT) score and bmodified Medical Research Council (mMRC) dyspnea-scale score, with misdiagnosed patients excluded (n=135).
Figure 4 Medication use in the GOLD ABCD treatment groups generated using the COPD- assessment test for symptom evaluation.
Figure 5 Pie chart showing medication among the patients. Appropriate medication defined as receiving medication as described by the GOLD ABCD medication group with/without add-ons for dyspnea and/or exacerbations.
Table 3 Nonpharmacological treatment
Table 4 Characteristics of GPs who continued using the digital CDSS after study conclusion